A full range of therapeutic antibody discovery services that leverage the suite of OmniAb technologies
OmniAb can help enhance the discovery process for antibody-based therapeutics.
Our project teams work closely with partners to customize and optimize therapeutic monoclonal antibody (mAb) discovery for each campaign.
Discovery with transgenic rodents
There are two options for antibody discovery with OmniRat®, OmniMouse®, and OmniFlic®:
- Receive animals directly and perform antibody discovery at your facility
- Choose an OmniAb authorized service provider to perform discovery for you
The OmniAb team will work with you to select the best option for your organization.
All OmniRat, OmniMouse, and OmniFlic animals are bred on multiple genetic backgrounds, maintained, and supplied by Charles River Laboratories and Taconic. Each breeder maintains master colonies of each animal type for OmniAb licensees and CROs.
Discovery with transgenic chickens and OmniTaur™
Partnerships with Contract Research Organizations (CROs)
OmniAb works with a comprehensive network of international contract research organizations (CROs) with substantial experience generating OmniAb antibodies and with expertise in characterization, bioinformatics, cell line development, and GMP manufacturing. Current CROs include: